$91.12
+1.26 (+1.40%)
At Close: Jun 03, 2026
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter
01:53pm, Tuesday, 17'th Feb 2026
Nine Ten Capital Management sold 342,907 shares of IRadimed; the estimated transaction value was $29.42 million based on quarterly average price. The quarter-end position value decreased by $13.21 mil
Why Iradimed Stock Soared Today
05:12pm, Tuesday, 10'th Feb 2026
For the 18th time in a row, the niche medical device maker set a new all-time high for quarterly revenue. It also handily topped the consensus analyst estimate for adjusted net profit.
IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript
01:14pm, Tuesday, 10'th Feb 2026
IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript
ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and year ended December
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts
06:13am, Tuesday, 20'th Jan 2026
Shares of iRadimed Corporation (NASDAQ: IRMD - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are presently covering the firm, MarketBeat reports.
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock
05:24am, Thursday, 01'st Jan 2026
iRadimed Corporation (NASDAQ: IRMD - Get Free Report) CEO Roger Susi sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, December 29th. The shares were sold at an average p
Copeland Capital Management LLC Has $30.85 Million Holdings in iRadimed Corporation $IRMD
04:52am, Tuesday, 30'th Dec 2025
Copeland Capital Management LLC lowered its position in shares of iRadimed Corporation (NASDAQ: IRMD) by 5.3% during the third quarter, according to the company in its most recent disclosure with the
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
08:30am, Monday, 08'th Dec 2025
ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0
STERIS (NYSE:STE) & iRadimed (NASDAQ:IRMD) Head to Head Comparison
02:20am, Wednesday, 03'rd Dec 2025
STERIS (NYSE: STE - Get Free Report) and iRadimed (NASDAQ: IRMD - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strengt
Analyzing Thermo Fisher Scientific (NYSE:TMO) and iRadimed (NASDAQ:IRMD)
02:30am, Tuesday, 02'nd Dec 2025
Thermo Fisher Scientific (NYSE: TMO - Get Free Report) and iRadimed (NASDAQ: IRMD - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies bas
iRadimed Corporation (NASDAQ:IRMD) Receives Average Recommendation of “Moderate Buy” from Analysts
01:26am, Monday, 01'st Dec 2025
Shares of iRadimed Corporation (NASDAQ: IRMD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are covering the firm, MarketBeat reports. One rese
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
09:00am, Monday, 10'th Nov 2025
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance
Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216
11:37am, Sunday, 09'th Nov 2025
Iradimed's CEO, President, and Chairman of the Board, Roger Susi, recently sold 5,000 shares on the open market. The transaction represented roughly 1% of his indirect holdings.
Spire Wealth Management Acquires New Holdings in iRadimed Corporation $IRMD
03:32am, Thursday, 06'th Nov 2025
Spire Wealth Management purchased a new position in shares of iRadimed Corporation (NASDAQ: IRMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commis
AlphaQuest LLC Reduces Holdings in iRadimed Corporation $IRMD
03:55am, Tuesday, 04'th Nov 2025
AlphaQuest LLC lowered its position in shares of iRadimed Corporation (NASDAQ: IRMD) by 58.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commis
Sign In
Buy IRMD